Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
SPY | Ann: SPH Notice - Wilson Asset Management Group | 06/09/24 | 0 | 62 | |||
|
|||||||
SPY | Ann: Capital Change Notice | 02/09/24 | 0 | 83 | |||
|
|||||||
SPY | Ann: Capital Change Notice | 30/08/24 | 0 | 57 | |||
|
|||||||
SPY | Ann: Capital Change Notice | 29/08/24 | 0 | 49 | |||
|
|||||||
SPY | Ann: Capital Change Notice | 28/08/24 | 0 | 83 | |||
|
|||||||
SPY | Ann: SPY Acquires Business Assets of Technology Holdings Ltd | 27/08/24 | 0 | 64 | |||
|
|||||||
SPY | Ann: Director Announcement - Shelley Ruha | 26/08/24 | 0 | 64 | |||
|
|||||||
SPY | Ann: Amended: Share Performance Rights & Capital Management | 19/08/24 | 0 | 104 | |||
|
See All Discussions